Early Morning Insight: Medtronic, Vertex Pharma, Orexigen Therapeutics, and Nanosphere
Editor Note: For more information about this release, please scroll to bottom.
15 Jul, 2013, 09:40 ET
LONDON, July 15, 2013 /PRNewswire/ --
On Friday, July 12, 2013, shares in healthcare companies ended on a mixed note even as the broader market managed to post gains. The major movers in the sector included Medtronic Inc. (NYSE: MDT), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Orexigen Therapeutics Inc. (NASDAQ: OREX), Nanosphere Inc. (NASDAQ: NSPH). All these companies are tracked by AAAResearchReports.com. Download free technical analysis and charting reports on MDT, VRTX, OREX, and NSPH now at:
Shares in Medtronic Inc. edged lower on Friday, reversing some of their gains for the week. The company's shares oscillated between $52.80 and $53.55 before finishing the day 0.56% lower at $53.44. A total of 5.87 million shares were traded which is above the daily average volume of 5.30 million. Despite Friday's pullback, the company's shares managed to gain 1.97% last week. In the last three months, Medtronic's shares have gained 13.22%, outperforming the S&P 500 which has gained 5.75% in the same period. Moreover, the stock is currently trading near its 52-week high of $53.83. Download free research on MDT today by registering at:
Vertex Pharmaceuticals Inc.'s stock rose sharply on Friday, extending its gains from previous trading sessions. The company's shares ended the session 3.65% higher at $87.79 after hitting a 52-week high of $88.00. A total of 2.09 million shares were traded which is above the daily average volume of 1.63 million. The company's shares have gained 9.75% in the last three trading sessions and 57.50% in the last three months, thus outperforming the S&P 500 during both the periods. Sign up and have access to our free report on VRTX at:
Shares in Orexigen Therapeutics Inc. moved higher on Friday, tracking gains in the broader market. The company's shares oscillated between $6.05 and $6.39 before closing the day 2.76% higher at $6.34. A total of 1.30 million shares were traded which is slightly above the daily average 1.22 million. The company's shares have gained 5.32% in the last three trading sessions and 4.79% in the last three months. Sign up and read the complimentary report on OREX at:
Nanosphere Inc.'s stock fell sharply on Friday even as the broader market posted gains. The company's shares oscillated between $3.16 and $3.53 before finishing 5.81% lower at $3.24. A total of 868,123 shares were traded which is below the daily average volume of 919,041. The company's shares have gained 1.89% in the last three trading sessions and 29.08% in the last three months, hence outperforming the S&P 500 during both the periods. Furthermore, the stock is still trading above its 200-day moving average. The free report on NSPH can be downloaded by signing up now at:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE AAA Research Reports
Share this article